Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.

Sun Y, Hawkins PG, Bi N, Dess RT, Tewari M, Hearn JWD, Hayman JA, Kalemkerian GP, Lawrence TS, Ten Haken RK, Matuszak MM, Kong FM, Jolly S, Schipper MJ.

Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):107-114. doi: 10.1016/j.ijrobp.2017.08.039. Epub 2017 Sep 4.

2.

Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer.

Hawkins PG, Sun Y, Dess RT, Jackson WC, Sun G, Bi N, Tewari M, Hayman JA, Kalemkerian GP, Gadgeel SM, Lawrence TS, Haken RKT, Matuszak MM, Kong FS, Schipper MJ, Jolly S.

J Cancer Res Clin Oncol. 2019 Jun;145(6):1635-1643. doi: 10.1007/s00432-019-02903-5. Epub 2019 Mar 28.

PMID:
30923943
3.

Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.

Chen X, Xu Y, Liao X, Liao R, Zhang L, Niu K, Li T, Li D, Chen Z, Duan Y, Sun J.

Tumour Biol. 2016 Sep;37(9):11927-11936. Epub 2016 Apr 13.

4.

Image guided hypofractionated 3-dimensional radiation therapy in patients with inoperable advanced stage non-small cell lung cancer.

Osti MF, Agolli L, Valeriani M, Falco T, Bracci S, De Sanctis V, Enrici RM.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):e157-63. doi: 10.1016/j.ijrobp.2012.10.012. Epub 2012 Nov 20.

PMID:
23182393
5.

The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.

Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Finkelstein SE, Shafman TD, Dosoretz AP, Evans SB, Husain ZA, Yu JB, Gross CP, Decker RH.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1011-1020. doi: 10.1016/j.ijrobp.2016.08.033. Epub 2016 Aug 31.

PMID:
27869080
6.

Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.

Wang J, Zhou Z, Liang J, Feng Q, Xiao Z, Hui Z, Wang X, Lv J, Chen D, Zhang H, Ji Z, Cao J, Liu L, Jiang W, Men Y, Xu C, Dai J, Yin W, Wang L.

Oncologist. 2016 Dec;21(12):1530-1537. Epub 2016 Sep 14.

7.

High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.

Xu X, Zhu S, Tao Z, Ye S.

Cancer Med. 2018 Jan;7(1):21-31. doi: 10.1002/cam4.1238. Epub 2017 Dec 21.

8.

Circulating miR-29a and miR-150 correlate with delivered dose during thoracic radiation therapy for non-small cell lung cancer.

Dinh TK, Fendler W, Chałubińska-Fendler J, Acharya SS, O'Leary C, Deraska PV, D'Andrea AD, Chowdhury D, Kozono D.

Radiat Oncol. 2016 Apr 27;11:61. doi: 10.1186/s13014-016-0636-4.

9.

Changes of circulating transforming growth factor-beta1 level during radiation therapy are correlated with the prognosis of locally advanced non-small cell lung cancer.

Zhao L, Ji W, Zhang L, Ou G, Feng Q, Zhou Z, Lei M, Yang W, Wang L.

J Thorac Oncol. 2010 Apr;5(4):521-5. doi: 10.1097/JTO.0b013e3181cbf761.

10.

Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.

Fan L, Qi H, Teng J, Su B, Chen H, Wang C, Xia Q.

Tumour Biol. 2016 Jun;37(6):7777-84. doi: 10.1007/s13277-015-4608-3. Epub 2015 Dec 22.

PMID:
26695145
11.

Upregulation of serum miR-494 predicts poor prognosis in non-small cell lung cancer patients.

Zhang J, Wang T, Zhang Y, Wang H, Wu Y, Liu K, Pei C.

Cancer Biomark. 2018;21(4):763-768. doi: 10.3233/CBM-170337.

PMID:
29286916
12.

Risk factors for brain metastases in locally advanced non-small cell lung cancer with definitive chest radiation.

Ji Z, Bi N, Wang J, Hui Z, Xiao Z, Feng Q, Zhou Z, Chen D, Lv J, Liang J, Fan C, Liu L, Wang L.

Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):330-7. doi: 10.1016/j.ijrobp.2014.02.025. Epub 2014 Apr 8.

PMID:
24725335
13.

Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.

Liu Y, Zhang G, Li H, Han L, Fu A, Zhang N, Zheng Y.

Biomed Pharmacother. 2015 Oct;75:185-90. doi: 10.1016/j.biopha.2015.07.026. Epub 2015 Aug 31.

PMID:
26337230
14.

Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.

Chen GY, Jiang GL, Qian H, Wang LJ, Yang HJ, Fu XL, Wu KL, Zang Z, Zhao S.

Radiother Oncol. 2004 May;71(2):157-62.

PMID:
15110448
15.

Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.

Xiang L, Zhang JW, Lin S, Luo HQ, Wen QL, He LJ, Shang CL, Ren PR, Yang HR, Pang HW, Yang B, He HL, Chen Y, Wu JB.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1027-1034. doi: 10.1016/j.ijrobp.2015.04.019. Epub 2015 Apr 17.

PMID:
26194678
16.

Pathway-based serum microRNA profiling and survival in patients with advanced stage non-small cell lung cancer.

Wang Y, Gu J, Roth JA, Hildebrandt MA, Lippman SM, Ye Y, Minna JD, Wu X.

Cancer Res. 2013 Aug 1;73(15):4801-9. doi: 10.1158/0008-5472.CAN-12-3273. Epub 2013 Jun 17.

17.

Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National Cancer Data Base.

Jegadeesh N, Liu Y, Gillespie T, Fernandez F, Ramalingam S, Mikell J, Lipscomb J, Curran WJ, Higgins KA.

Clin Lung Cancer. 2016 Sep;17(5):398-405. doi: 10.1016/j.cllc.2016.01.007. Epub 2016 Feb 2.

PMID:
26936682
18.

Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.

Wang S, Campbell J, Stenmark MH, Zhao J, Stanton P, Matuszak MM, Ten Haken RK, Kong FS.

Int J Radiat Oncol Biol Phys. 2017 Jul 1;98(3):615-621. doi: 10.1016/j.ijrobp.2017.03.011. Epub 2017 Mar 14.

19.

Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.

Agolli L, Valeriani M, Bracci S, Nicosia L, DE Sanctis V, Enrici RM, Osti MF.

Anticancer Res. 2015 Oct;35(10):5693-700.

PMID:
26408745
20.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP.

J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. Review.

PMID:
20351327

Supplemental Content

Support Center